Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Leber » Leberzirrhose 20. Februar 2019
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
Portale Hypertonie
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1295  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 25896  
PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
BMJ Open
Woodhouse CA, Patel VC, Goldenberg S, Sanchez-Fueyo A, China L, O'Brien A, Flach C, Douiri A, Shawcross D.
PMID: 30772848 [PubMed - in process]

Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis.
Clin Gastroenterol Hepatol
Chen WC, Hsin IF, Chen PH, Hsu PI, Wang YP, Cheng JS, Lin HS, Hou MC, Lee FY.
PMID: 30772583 [PubMed - as supplied by publisher]

The impact and evolution of acute-on-chronic liver failure in decompensated cirrhosis: A Portuguese single-center study.
Gastroenterol Hepatol
Ferreira Cardoso M, Alexandrino G, Carvalho E Branco J, Anapaz V, Carvalho R, Horta D, Martins A.
PMID: 30772084 [PubMed - as supplied by publisher]

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
Intagliata NM, Caldwell SH, Tripodi A.
PMID: 30771355 [PubMed - as supplied by publisher]

MRI texture analysis for differentiation of malignant and benign hepatocellular tumors in the non-cirrhotic liver.
Stocker D, Marquez HP, Wagner MW, Raptis DA, Clavien PA, Boss A, Fischer MA, Wurnig MC.
PMID: 30761374 [PubMed]

Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial.
Yang X, Ru S, Luo L, Lv X, Bai W, Zhang F, Jiang F.
PMID: 30760320 [PubMed - in process]

Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
Hepatol Int
Hanafy AS, Bassiony MA, Basha MAA.
PMID: 30758786 [PubMed - as supplied by publisher]

The predictive value of future liver remnant function after liver resection for HCC in noncirrhotic and cirrhotic patients.
HPB (Oxford)
Blüthner E, Jara M, Shrestha R, Faber W, Pratschke J, Stockmann M, Malinowski M.
PMID: 30733048 [PubMed - as supplied by publisher]

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study.
Medicine (Baltimore)
Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E.
PMID: 30732215 [PubMed - in process]

Are Predictive Energy Expenditure Equations Accurate in Cirrhosis?
Eslamparast T, Vandermeer B, Raman M, Gramlich L, Den Heyer V, Belland D, Ma M, Tandon P.
PMID: 30720726 [PubMed - in process]

L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses.
Butterworth RF, McPhail MJW.
PMID: 30706425 [PubMed - as supplied by publisher]

Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.
Butterworth RF.
PMID: 30706423 [PubMed - as supplied by publisher]

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.
Montagnese S, Bajaj JS.
PMID: 30706419 [PubMed - as supplied by publisher]

Associated vitamin D deficiency is a risk factor for the complication of HCV-related liver cirrhosis including hepatic encephalopathy and spontaneous bacterial peritonitis.
Intern Emerg Med
Yousif MM, Sadek AMEM, Farrag HA, Selim FO, Hamed EF, Salama RI.
PMID: 30706253 [PubMed - as supplied by publisher]

Interventions to improve sarcopenia in cirrhosis: A systematic review.
World J Clin Cases
Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V.
PMID: 30705893 [PubMed]

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
World J Hepatol
Desai A, Sandhu S, Lai JP, Sandhu DS.
PMID: 30705715 [PubMed]

Laparoscopic Versus Open Hepatectomy in Short- and Long-Term Outcomes of the Hepatocellular Carcinoma Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
J Laparoendosc Adv Surg Tech A
Jiang S, Wang Z, Ou M, Pang Q, Fan D, Cui P.
PMID: 30702362 [PubMed - as supplied by publisher]

Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review.
BMJ Open
Härmälä S, Parisinos C, Ryan J, O'Brien A.
PMID: 30700489 [PubMed - in process]

Hepatocellular Carcinoma versus Other Hepatic Malignancy in Cirrhosis: Performance of LI-RADS Version 2018.
Kim YY, Kim MJ, Kim EH, Roh YH, An C.
PMID: 30694166 [PubMed - as supplied by publisher]

JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-infected Patients without Cirrhosis: OMEGA-1.
Zeuzem S, Bourgeois S, Greenbloom S, Buti M, Aghemo A, Lampertico P, Janczewska E, Lim SG, Moreno C, Buggisch P, Tam E, Corbett C, Willems W, Vijgen L, Fevery B, Ouwerkerk-Mahadevan S, Ackaert O, Beumont M, Kalmeijer R, Sinha R, Biermer M, OMEGA-1 study team..
PMID: 30693573 [PubMed - as supplied by publisher]

   Artikel 1 - 20 / 25896    Seite 1 von 1295  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1